Scarica l'app Stockscreener
119.37
2.97%
3.5257
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$115.84
Aprire:
$116.9
Volume 24 ore:
8.44M
Relative Volume:
0.60
Capitalizzazione di mercato:
$296.35B
Reddito:
$65.00B
Utile/perdita netta:
$18.26B
Rapporto P/E:
16.41
EPS:
7.2751
Flusso di cassa netto:
$13.05B
1 W Prestazione:
+11.58%
1M Prestazione:
+12.05%
6M Prestazione:
+49.36%
1 anno Prestazione:
+31.45%
Intervallo 1D:
$116.50
$119.93
Intervallo di 1 settimana:
$107.10
$119.93
Portata 52W:
$73.31
$119.93
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Confronta MRK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
119.40 | 287.52B | 65.00B | 18.26B | 13.05B | 7.2751 |
|
LLY
Lilly Eli Co
|
1,091.51 | 898.12B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
234.64 | 561.61B | 94.19B | 26.80B | 20.46B | 11.05 |
|
ABBV
Abbvie Inc
|
210.28 | 398.83B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
152.09 | 287.55B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-08 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-10-13 | Ripresa | Citigroup | Neutral |
| 2025-09-17 | Downgrade | Berenberg | Buy → Hold |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-08 | Downgrade | Truist | Buy → Hold |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-12-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-11 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
Wells Fargo & Company Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Q4 2025 Earnings Call Transcript - Insider Monkey
Ashton Thomas Private Wealth LLC Acquires 43,047 Shares of Merck & Co., Inc. $MRK - MarketBeat
Payne Capital LLC Purchases Shares of 10,540 Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. Q4 Earnings Call Highlights - Yahoo Finance
Merck & Co., Inc. (NYSE:MRK) Trading Up 2.2% on Earnings Beat - MarketBeat
Merck Looks Ahead To Phase III-Rich Period As Keytruda Winds Down - Citeline News & Insights
Merck & Co Inc (MRK) Q4 2025 Earnings Call Highlights: Strong Gr - GuruFocus
AI for investors - MLQ.ai
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline - BioSpace
Merck's Annual Outlook Falls Short But Keytruda, Animal Health Segments Grow - Benzinga
Merck & Co., Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
Merck shares dip as 2026 outlook misses Wall Street expectations - Proactive financial news
Merck’s Full Year Forecast Misses Expectations on Gardasil Woes - Bloomberg.com
Merck & Co., Inc. (NYSE:MRK) Issues FY 2026 Earnings Guidance - MarketBeat
Merck & Co., Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Merck beats on fourth quarter revenue but disappoints on outlook - Sharecast News
Merck & Co. Inc. (NYSE:MRK) Beats Q4 Estimates but 2026 Outlook Cautions Investors - Chartmill
Jim Cramer on Merck & Co.: "I Think It Can Spread Out the Wealth" - Finviz
Jim Cramer on Merck & Co.: “I Think It Can Spread Out the Wealth” - Yahoo Finance UK
Merck stock dips as 2026 outlook falls short of expectations (MRK:NYSE) - Seeking Alpha
Our Q4 and full-year 2025 financial results - Merck.com
Merck & Co., Inc. 8-K Filing Analysis - TradingView
Merck & Co., Inc. $MRK Shares Sold by Jones Financial Companies Lllp - MarketBeat
Merck's Q4 sales rise by 5% to $16.4B - breakingthenews.net
Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline - Business Wire
Where is Merck & Co. (MRK) headed according to Wall Street? - MSN
Where is Merck & Co. (MRK) Headed According to Wall Street? - Finviz
Does Merck & Co. (NYSE:MRK) Maintain Pharma Reach In S&P 500 Fund - Kalkine Media
Pfizer, Merck And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Merck & Co., Inc. (NYSE:MRK) Shares Up 2.9%Time to Buy? - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Reaches New 12-Month HighHere's Why - MarketBeat
Merck Q4 2025 Earnings Preview (MRK:NYSE) - Seeking Alpha
A Look Ahead: Merck & Co's Earnings Forecast - Benzinga
Merck & Co., Inc. $MRK Shares Sold by Woodmont Investment Counsel LLC - MarketBeat
Merck (MRK) Q4 Earnings Report Preview: What To Look For - Finviz
Mediolanum International Funds Ltd Raises Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK is Atle Fund Management AB's 4th Largest Position - MarketBeat
Principal Financial Group Inc. Decreases Stake in Merck & Co., Inc. $MRK - MarketBeat
Thrivent Financial for Lutherans Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Independent Advisor Alliance Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK) joins BofA’s US 1 list - MSN
Merck & Co., Inc. (MRK) Joins BofA's "US 1 List" - Finviz
Merck & Co., Inc. (MRK) Joins BofA’s “US 1 List” - Insider Monkey
Cantor Fitzgerald Sees Deal Activity and Pipeline Progress as Key for Merck’s (MRK) Next Phase - Insider Monkey
Keybank National Association OH Trims Position in Merck & Co., Inc. $MRK - MarketBeat
Federated Hermes Inc. Sells 307,109 Shares of Merck & Co., Inc. $MRK - MarketBeat
National Pension Service Purchases 175,582 Shares of Merck & Co., Inc. $MRK - MarketBeat
Winnow Wealth LLC Purchases 12,091 Shares of Merck & Co., Inc. $MRK - MarketBeat
Centric Wealth Management Trims Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Technical Breakout Setup for Merck & Co. Inc. (NYSE:MRK) - Chartmill
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.42%
6.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):